| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 48.10M | — |
| Operating expense | — | — |
| Net income | -260.54M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 24H.F returned +28.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8.5% |
| 1 year | +28.8% |
| 5 years | -69.0% |
| All-time high | €31.60 (Sep 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 24H.F would be worth today ›No. Hansa Biopharma AB (publ) has not paid a dividend in the past 12 months.
Hansa Biopharma AB (publ) is part of the Healthcare sector.
Hansa Biopharma AB (publ) has a market cap of 367.82M EUR, based on the latest quote.
